home / stock / mreo / mreo quote
Last: | $3.20 |
---|---|
Change Percent: | 0.0% |
Open: | $3.27 |
Close: | $3.20 |
High: | $3.27 |
Low: | $3.09 |
Volume: | 439,196 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.2 | $3.27 | $3.2 | $3.27 | $3.09 | 439,196 | 05-17-2024 |
$3.27 | $3.15 | $3.27 | $3.345 | $3.15 | 759,943 | 05-16-2024 |
$3.17 | $2.99 | $3.17 | $3.17 | $2.9809 | 546,347 | 05-15-2024 |
$2.96 | $3 | $2.96 | $3.06 | $2.93 | 534,118 | 05-14-2024 |
$2.97 | $3.04 | $2.97 | $3.14 | $2.97 | 473,572 | 05-13-2024 |
$3.03 | $3.25 | $3.03 | $3.33 | $3.03 | 847,740 | 05-10-2024 |
$3.27 | $3.1 | $3.27 | $3.29 | $3.04 | 499,616 | 05-09-2024 |
$3.1 | $2.99 | $3.1 | $3.135 | $2.92 | 537,070 | 05-08-2024 |
$3.01 | $3.09 | $3.01 | $3.13 | $2.97 | 687,644 | 05-07-2024 |
$3.1 | $3.3 | $3.1 | $3.31 | $3.01 | 834,894 | 05-06-2024 |
$3.26 | $3.16 | $3.26 | $3.35 | $3.14 | 855,585 | 05-03-2024 |
$3.11 | $3.18 | $3.11 | $3.24 | $3.11 | 431,767 | 05-02-2024 |
$3.15 | $3.06 | $3.15 | $3.22 | $3.01 | 1,962,063 | 05-01-2024 |
$3.05 | $2.75 | $3.05 | $3.09 | $2.71 | 1,579,127 | 04-30-2024 |
$2.76 | $2.75 | $2.76 | $2.815 | $2.6701 | 530,508 | 04-29-2024 |
$2.74 | $2.81 | $2.74 | $2.81 | $2.73 | 562,550 | 04-26-2024 |
$2.81 | $2.75 | $2.81 | $2.82 | $2.64 | 1,031,323 | 04-25-2024 |
$2.78 | $2.76 | $2.78 | $2.885 | $2.76 | 572,866 | 04-24-2024 |
$2.78 | $2.81 | $2.78 | $2.851 | $2.75 | 790,447 | 04-23-2024 |
$2.79 | $2.73 | $2.79 | $2.81 | $2.6201 | 1,064,979 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Mereo BioPharma Group Company Name:
MREO Stock Symbol:
NASDAQ Market:
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the first quarter ended March 31, 2024, and prov...
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutica...
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate ...